Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Vision Screening | 8 | 2020 | 40 | 1.520 |
Why?
|
| Strabismus | 2 | 2015 | 37 | 1.010 |
Why?
|
| Oculomotor Muscles | 3 | 2018 | 54 | 0.920 |
Why?
|
| Amblyopia | 6 | 2020 | 43 | 0.880 |
Why?
|
| Dyskeratosis Congenita | 1 | 2021 | 2 | 0.840 |
Why?
|
| Retinal Telangiectasis | 1 | 2021 | 2 | 0.840 |
Why?
|
| Ocular Motility Disorders | 2 | 2018 | 15 | 0.820 |
Why?
|
| Bone Diseases, Metabolic | 1 | 2021 | 30 | 0.820 |
Why?
|
| Bone Marrow | 1 | 2021 | 168 | 0.780 |
Why?
|
| Retina | 2 | 2021 | 252 | 0.740 |
Why?
|
| Orbit | 1 | 2018 | 30 | 0.640 |
Why?
|
| Torsion Abnormality | 2 | 2014 | 12 | 0.490 |
Why?
|
| Orthoptics | 1 | 2014 | 3 | 0.490 |
Why?
|
| Optical Devices | 1 | 2014 | 7 | 0.480 |
Why?
|
| Refraction, Ocular | 3 | 2017 | 61 | 0.400 |
Why?
|
| Infant | 8 | 2021 | 2891 | 0.350 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2018 | 2222 | 0.340 |
Why?
|
| Eye Movements | 3 | 2014 | 44 | 0.340 |
Why?
|
| Reproducibility of Results | 7 | 2018 | 2077 | 0.310 |
Why?
|
| Eye Diseases | 2 | 2013 | 38 | 0.280 |
Why?
|
| Child, Preschool | 10 | 2018 | 3185 | 0.270 |
Why?
|
| Fundus Oculi | 3 | 2021 | 33 | 0.260 |
Why?
|
| Predictive Value of Tests | 6 | 2020 | 1465 | 0.250 |
Why?
|
| Fluorescein Angiography | 3 | 2021 | 57 | 0.240 |
Why?
|
| Equipment Design | 4 | 2020 | 500 | 0.240 |
Why?
|
| Prospective Studies | 8 | 2020 | 3702 | 0.230 |
Why?
|
| Female | 16 | 2021 | 38015 | 0.220 |
Why?
|
| Child | 10 | 2021 | 6400 | 0.220 |
Why?
|
| Myopia | 2 | 2018 | 27 | 0.210 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 2021 | 6 | 0.200 |
Why?
|
| Edema | 1 | 2021 | 66 | 0.200 |
Why?
|
| Adolescent | 8 | 2020 | 8903 | 0.200 |
Why?
|
| Visual Acuity | 3 | 2017 | 236 | 0.200 |
Why?
|
| Sarcoidosis | 1 | 2021 | 77 | 0.190 |
Why?
|
| Hyperopia | 2 | 2018 | 14 | 0.190 |
Why?
|
| Vision, Monocular | 2 | 1999 | 7 | 0.180 |
Why?
|
| Humans | 21 | 2021 | 68525 | 0.180 |
Why?
|
| Sensitivity and Specificity | 4 | 2018 | 1753 | 0.180 |
Why?
|
| Vision Disparity | 1 | 1999 | 3 | 0.180 |
Why?
|
| False Positive Reactions | 2 | 2018 | 95 | 0.180 |
Why?
|
| Smartphone | 1 | 2020 | 69 | 0.170 |
Why?
|
| Exudates and Transudates | 1 | 1999 | 25 | 0.170 |
Why?
|
| Vitreous Body | 1 | 1999 | 26 | 0.170 |
Why?
|
| Retinal Diseases | 1 | 1999 | 40 | 0.170 |
Why?
|
| Male | 16 | 2020 | 37281 | 0.160 |
Why?
|
| Angioid Streaks | 1 | 1997 | 1 | 0.160 |
Why?
|
| Pseudoxanthoma Elasticum | 1 | 1997 | 3 | 0.160 |
Why?
|
| Optic Disk | 2 | 2013 | 37 | 0.150 |
Why?
|
| Optic Nerve | 2 | 2016 | 55 | 0.150 |
Why?
|
| Eye Diseases, Hereditary | 1 | 2016 | 10 | 0.150 |
Why?
|
| Optics and Photonics | 1 | 2016 | 29 | 0.150 |
Why?
|
| Neuronal Ceroid-Lipofuscinoses | 1 | 2016 | 4 | 0.140 |
Why?
|
| Developmental Disabilities | 1 | 2017 | 119 | 0.140 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 68 | 0.140 |
Why?
|
| Molecular Chaperones | 1 | 2016 | 81 | 0.130 |
Why?
|
| Eye | 1 | 2016 | 89 | 0.130 |
Why?
|
| Leber Congenital Amaurosis | 1 | 2015 | 7 | 0.130 |
Why?
|
| Photoreceptor Cells, Vertebrate | 1 | 2015 | 46 | 0.130 |
Why?
|
| Refractive Errors | 1 | 2014 | 24 | 0.120 |
Why?
|
| Eye Proteins | 1 | 2015 | 160 | 0.120 |
Why?
|
| Membrane Glycoproteins | 1 | 2016 | 370 | 0.120 |
Why?
|
| Orbital Neoplasms | 1 | 2013 | 21 | 0.110 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2015 | 145 | 0.110 |
Why?
|
| Rhabdomyosarcoma | 1 | 2013 | 36 | 0.110 |
Why?
|
| Genetic Therapy | 1 | 2015 | 291 | 0.110 |
Why?
|
| Carrier Proteins | 1 | 2015 | 597 | 0.100 |
Why?
|
| Risk Factors | 5 | 2020 | 5719 | 0.090 |
Why?
|
| Young Adult | 3 | 2020 | 5708 | 0.090 |
Why?
|
| Adult | 6 | 2020 | 21375 | 0.080 |
Why?
|
| Referral and Consultation | 2 | 2020 | 383 | 0.070 |
Why?
|
| Convergence, Ocular | 2 | 1999 | 3 | 0.060 |
Why?
|
| Afterimage | 1 | 1999 | 1 | 0.050 |
Why?
|
| Vision Tests | 1 | 1999 | 18 | 0.040 |
Why?
|
| Coloboma | 1 | 1998 | 2 | 0.040 |
Why?
|
| Nystagmus, Pathologic | 1 | 1998 | 12 | 0.040 |
Why?
|
| Anisometropia | 1 | 2018 | 12 | 0.040 |
Why?
|
| Ciliary Body | 1 | 1998 | 52 | 0.040 |
Why?
|
| Astigmatism | 1 | 2018 | 17 | 0.040 |
Why?
|
| Retinal Vessels | 1 | 1998 | 74 | 0.040 |
Why?
|
| Neurologic Examination | 1 | 2017 | 107 | 0.040 |
Why?
|
| Physical Examination | 1 | 2018 | 152 | 0.040 |
Why?
|
| Adaptation, Physiological | 1 | 1998 | 189 | 0.040 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 1 | 2016 | 19 | 0.040 |
Why?
|
| Atrophy | 1 | 2016 | 112 | 0.030 |
Why?
|
| Kidney Diseases | 1 | 1998 | 307 | 0.030 |
Why?
|
| Retinoscopy | 1 | 2014 | 11 | 0.030 |
Why?
|
| Tomography, Optical Coherence | 1 | 2015 | 88 | 0.030 |
Why?
|
| Ophthalmology | 1 | 2014 | 39 | 0.030 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2015 | 214 | 0.030 |
Why?
|
| Middle Aged | 2 | 2020 | 21119 | 0.030 |
Why?
|
| Prevalence | 1 | 2014 | 1609 | 0.020 |
Why?
|
| Practice Guidelines as Topic | 1 | 2014 | 772 | 0.020 |
Why?
|
| Disease Progression | 1 | 2013 | 1037 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 3256 | 0.020 |
Why?
|
| Time Factors | 1 | 2013 | 4655 | 0.020 |
Why?
|
| Fixation, Ocular | 1 | 1998 | 13 | 0.010 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 1998 | 21 | 0.010 |
Why?
|
| Electroretinography | 1 | 1998 | 122 | 0.010 |
Why?
|
| Syndrome | 1 | 1998 | 255 | 0.010 |
Why?
|
| Reference Values | 1 | 1998 | 579 | 0.010 |
Why?
|
| Homeostasis | 1 | 1998 | 291 | 0.010 |
Why?
|
| Ultrasonography | 1 | 1998 | 453 | 0.010 |
Why?
|
| Aged | 1 | 1998 | 14842 | 0.000 |
Why?
|